Endoscopic submucosal dissection for papillary early gastric carcinoma: Insights from a large-scale analysis of post-gastrectomy pathology specimens

Gastric papillary adenocarcinoma is considered a differentiated adenocarcinoma in the current endoscopic submucosal dissection indication guidelines. However, the safety of endoscopic submucosal dissection remains controversial. Currently, data regarding which papillary early gastric cancer should be considered for endoscopic submucosal dissection are unavailable. Thus, the aim of this study was to investigate lymph node metastasis and the safety of endoscopic submucosal dissection in patients with papillary early gastric cancer. This observational study recruited 4264 consecutive patients with early gastric cancer who underwent curative gastrectomy between October 2000 and December 2017 at the National Cancer Center, Korea. Of these, 45 had pathologically confirmed papillary early gastric cancer, 2106 had differentiated non-papillary early gastric cancer, and 2113 had undifferentiated early gastric cancer. Logistic regression analysis was performed to identify risk factors for lymph node metastasis. Mucosal tumors were less common in papillary early gastric cancer (37.9%) than in differentiated non-papillary early gastric cancer (48.8%) and undifferentiated early gastric cancer (60.4%) (both P < .001). Lymph node metastasis was more common in papillary early gastric cancer (20.0%) than in differentiated non-papillary early gastric cancer (9.2%) and undifferentiated early gastric cancer (11.7%; both P < .001). In multivariate analysis, non-mixed-type papillary early gastric cancer showed marginally increased odds of lymph node metastasis than differentiated early gastric cancer (odds ratio [OR]: 2.5, 95% confidence interval [CI]: 1.0–6.3). Rates of lymph node metastasis (1/10, 10%) and angiolymphatic invasion (2/10, 20%) for papillary early gastric cancer meeting expanded criteria were higher than those for other histology types meeting endoscopic submucosal dissection absolute or expanded criteria (P = .03 and P < .001, respectively). Endoscopic submucosal dissection should be considered carefully for papillary early gastric cancer, especially if it meets expanded endoscopic submucosal dissection indications since it is associated with high rates of submucosal invasion and lymph node metastasis.

[1]  Hailong Xie,et al.  Risk Factors of Lymph Node Metastasis and Its Prognostic Significance in Early Gastric Cancer: A Multicenter Study , 2021, Frontiers in Oncology.

[2]  Jae Ho Park,et al.  Efficacy and safety of endoscopic submucosal dissection for papillary adenocarcinoma-type early gastric cancer , 2019, Medicine.

[3]  D. Park,et al.  Sa1304 – Clinicopathologic Features of Submucosal Papillary Gastric Cancer : Same to Other Differentiated Histology? , 2019, Gastroenterology.

[4]  Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach , 2019, Journal of gastric cancer.

[5]  M. Kook Risk Factors for Lymph Node Metastasis in Undifferentiated-Type Gastric Carcinoma , 2019, Clinical endoscopy.

[6]  Guo-Xin Zhang,et al.  A Comparison by Meta-Analysis of Papillary Early Gastric Carcinoma to Its Tubular Counterpart for the Risk of Lymph Node Metastasis and Submucosal Invasion , 2017, Journal of clinical gastroenterology.

[7]  Kyoung-Mee Kim,et al.  Endoscopic submucosal dissection for papillary adenocarcinoma of the stomach: low curative resection rate but favorable long-term outcomes after curative resection , 2018, Gastric Cancer.

[8]  Guoxin Zhang,et al.  The Characteristics, Prognosis, and Risk Factors of Lymph Node Metastasis in Early Gastric Cancer , 2018, Gastroenterology research and practice.

[9]  Kyoung-Mee Kim,et al.  Lymphovascular invasion and lymph node metastasis rates in papillary adenocarcinoma of the stomach: implications for endoscopic resection , 2018, Gastric Cancer.

[10]  D. Park,et al.  Endoscopic submucosal dissection for papillary adenocarcinoma of the stomach: is it really safe? , 2017, Gastric Cancer.

[11]  X. Zou,et al.  Worse Prognosis in Papillary, Compared to Tubular, Early Gastric Carcinoma , 2017, Journal of Cancer.

[12]  Japanese Gastric Cancer Association Japanese gastric cancer treatment guidelines 2014 (ver. 4) , 2016, Gastric Cancer.

[13]  Y. K. Park,et al.  Assessment of laparoscopic stomach preserving surgery with sentinel basin dissection versus standard gastrectomy with lymphadenectomy in early gastric cancer–A multicenter randomized phase III clinical trial (SENORITA trial) protocol , 2016, BMC Cancer.

[14]  M. Rugge,et al.  Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline , 2015, Endoscopy.

[15]  V. Barresi,et al.  Phagocytosis (cannibalism) of apoptotic neutrophils by tumor cells in gastric micropapillary carcinomas. , 2015, World journal of gastroenterology.

[16]  D. Park,et al.  Is endoscopic submucosal dissection safe for papillary adenocarcinoma of the stomach? , 2015, World journal of gastroenterology.

[17]  I. Oda,et al.  Clinical significance of a papillary adenocarcinoma component in early gastric cancer: a single-center retrospective analysis of 628 surgically resected early gastric cancers , 2015, Journal of Gastroenterology.

[18]  Junwei Luan,et al.  Tamoxifen reduces P-gp-mediated multidrug resistance via inhibiting the PI3K/Akt signaling pathway in ER-negative human gastric cancer cells. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[19]  S. Kim Endoscopic Treatment for Early Gastric Cancer , 2011, Journal of gastric cancer.

[20]  G. Vlastos,et al.  Impact of obesity on diagnosis and treatment of breast cancer , 2010, Breast Cancer Research and Treatment.

[21]  Matsuyoshi Maeda,et al.  Clinicopathological variables associated with lymph node metastasis in submucosal invasive gastric cancer , 2007, Gastric Cancer.

[22]  Shuji Fujita,et al.  Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state. , 2007, Cancer research.

[23]  Shinji Tanaka,et al.  Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer. , 2006, Gastrointestinal endoscopy.

[24]  K. Choe,et al.  Lymph node metastasis in early gastric cancer with submucosal invasion: feasibility of minimally invasive surgery. , 2004, World journal of gastroenterology.

[25]  Charles J. Lightdale,et al.  The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. , 2003, Gastrointestinal endoscopy.

[26]  H. Sugimura,et al.  Microsatellite instability of papillary subtype of human gastric adenocarcinoma and hMLH1 promoter hypermethylation in the surrounding mucosa , 2001, Pathology international.

[27]  Y. Nakanishi,et al.  Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers , 2000, Gastric Cancer.

[28]  S. Kitano,et al.  Papillary adenocarcinoma of the stomach , 2000, Gastric Cancer.